Atlantic Edge Private Wealth Management’s Vaxcyte PCVX Stock Holding History
Bought
Maintained
Sold
Other funds holding PCVX
Atlantic Edge Private Wealth Management's PCVX Position: Q3 2026 in Review
Atlantic Edge Private Wealth Management held its Vaxcyte (PCVX) position steady in Q3 2026 at 25 shares worth $1.42K. The position accounts for ﹤0.01% of the portfolio, ranked #584.
Atlantic Edge Private Wealth Management first reported a position in PCVX in Q4 2025 and has held it in 4 quarters since. The position peaked at $1.45K in Q2 2026. 356 funds tracked by Wall St. Rank hold PCVX as of Q3 2026.
- Atlantic Edge Private Wealth Management held 25 shares of Vaxcyte worth $1.42K as of Q3 2026.
- Atlantic Edge Private Wealth Management left its Vaxcyte share count unchanged in Q3 2026.
- Vaxcyte made up ﹤0.01% of Atlantic Edge Private Wealth Management's portfolio in Q3 2026, its #584 holding.
- Atlantic Edge Private Wealth Management first reported a position in Vaxcyte in Q4 2025 and has held it in 4 quarters since.
- Atlantic Edge Private Wealth Management's Vaxcyte position peaked at $1.45K in Q2 2026.
- 356 funds tracked by Wall St. Rank held Vaxcyte as of Q3 2026.
Based on Atlantic Edge Private Wealth Management's 13F filing for Q3 2026, filed 20 Oct 2026.